TETRALOGIC PHARMACEUTICALS CORP Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TLOG and buy or sell other stocks, ETFs, and their options commission-free!About TLOG
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE.
CEOJ. Kevin Buchi, MBA, CPA
CEOJ. Kevin Buchi, MBA, CPA
Employees11
Employees11
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2001
Founded2001
Employees11
Employees11
TLOG Key Statistics
Market cap4.89K
Market cap4.89K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.001
52 Week high$0.001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) shares are valued at $0.00. The company's market cap stands at 4.89K.
TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) stock opened on 2026-05-05 at —. The price climbed to — and dipped to —.
TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) shares are trading with a volume of 0.
In the last year, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.